Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Blueprint Medicines Corp shares valued at $216,075 were sold by Rossi Christina on Mar 24 ’25. At $95.02 per share, Rossi Christina sold 2,274 shares. The insider’s holdings dropped to 69,266 shares worth approximately $6.28 million following the completion of this transaction.
Also, Christina Rossi purchased 9,096 shares, netting a total of over 811,363 in proceeds.
Before that, Albers Jeffrey W. had sold 5,766 shares from its account. In a trade valued at $512,021, the Director traded Blueprint Medicines Corp shares for $88.80 each. Upon closing the transaction, the insider’s holdings decreased to 5,766 shares, worth approximately $13.3 million.
Analysts at Wolfe Research started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid March. As of March 17, 2025, Jefferies has initiated its “Buy” rating for BPMC. Earlier on March 07, 2025, Scotiabank initiated its rating. Their recommendation was “a Sector outperform” for BPMC stock.
Analyzing BPMC Stock Performance
During the last five days, there has been a surge of approximately 0.27%. Over the course of the year, Blueprint Medicines Corp shares have jumped approximately 4.01%. Shares of the company reached a 52-week high of $118.25 on 01/27/25 and a 52-week low of $84.59 on 03/10/25. A 50-day SMA is recorded $98.90, while a 200-day SMA reached $96.95.
Support And Resistance Levels for Blueprint Medicines Corp (BPMC)
According to the 24-hour chart, there is a support level at 89.88, which, if violated, would cause prices to drop to 89.05. In the upper region, resistance lies at 92.22. The next price resistance is at 93.73. RSI (Relative Strength Index) is 46.77 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 3.03, which suggests the price will increase in the coming days. Percent R is at 46.37%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
